SGK1 inhibitors for the prophylaxis and/ or therapy of viral diseases and/or carcinomas

Details for Australian Patent Application No. 2009217028 (hide)

Owner Merck Patent GmbH

Inventors Beier, Norbert; Gericke, Rolf; Lang, Philipp; Lang, Florian; Lang, Karl; Fuchss, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2009217028

PCT Pub. Number WO2009/103484

Priority 10 2008 010 361.6 18.02.08 DE

Filing date 17 February 2009

Wipo publication date 27 August 2009

International Classifications

C07C 243/38 (2006.01) Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/103484 Priority application(s): WO2009/103484

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217031-Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy

2009217021-Compositions for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer